Two therapeutic challenges: facial vitiligo successfully treated with 1% pimecrolimus cream and 0.005% calcipotriol cream.
Bilaç
D B
DB
Ermertcan
A T
AT
Sahin
M T
MT
Oztürkcan
S
S
D000293:Adolescent; D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016559:Tacrolimus / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014820:Vitiligo / Q000188:drug therapy*
D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; C055085:calcipotriene; C117268:pimecrolimus; D002117:Calcitriol; D016559:Tacrolimus